Factor | Wagner2008 (10130)

10.1128/aem.01132-07

Pulsed CTC Use

Swine | Grower-finisher

30

Description

Chlortetracycline was fed at 400 g/ton in a pulsed fashion: 1wk+, 3wk-, 1wk+, 12wk-.

Resistance Outcomes

Resistance Microbe Outcome
Tetracycline
/
Escherichia coli
See: Table 3 AMR+ (%) AMR- (%) Total (n)
Pulsed CTC Use 98.00 146
No Use 94.80 128
Ceftiofur
/
Salmonella spp. (Typing Performed)
See: Table 2 AMR+ (%) AMR- (%) Total (n)
Pulsed CTC Use 0.00 30
No Use 0.00 10
Ceftiofur
/
Escherichia coli
See: Table 3 AMR+ (%) AMR- (%) Total (n)
Pulsed CTC Use 0.00 146
No Use 0.80 128
Amoxicillin And Beta-Lactamase Inhibitor
/
Salmonella spp. (Typing Performed)
See: Table 2 AMR+ (%) AMR- (%) Total (n)
Pulsed CTC Use 0.00 30
No Use 0.00 10
Amoxicillin And Beta-Lactamase Inhibitor
/
Escherichia coli
See: Table 3 AMR+ (%) AMR- (%) Total (n)
Pulsed CTC Use 0.00 146
No Use 0.00 128
Ampicillin
/
Salmonella spp. (Typing Performed)
See: Table 2 AMR+ (%) AMR- (%) Total (n)
Pulsed CTC Use 60.00 30
No Use 10.00 10
Ampicillin
/
Escherichia coli
See: Table 3 AMR+ (%) AMR- (%) Total (n)
Pulsed CTC Use 31.50 146
No Use 27.30 128
Cefalotin
/
Salmonella spp. (Typing Performed)
See: Table 2 AMR+ (%) AMR- (%) Total (n)
Pulsed CTC Use 0.00 30
No Use 0.00 10
Cefalotin
/
Escherichia coli
See: Table 3 AMR+ (%) AMR- (%) Total (n)
Pulsed CTC Use 11.00 146
No Use 3.90 128
Cefoxitin
/
Escherichia coli
See: Table 3 AMR+ (%) AMR- (%) Total (n)
Pulsed CTC Use 0.00 146
No Use 0.00 128
Amikacin
/
Salmonella spp. (Typing Performed)
See: Table 2 AMR+ (%) AMR- (%) Total (n)
Pulsed CTC Use 0.00 30
No Use 0.00 10
Cefoxitin
/
Salmonella spp. (Typing Performed)
See: Table 2 AMR+ (%) AMR- (%) Total (n)
Pulsed CTC Use 0.00 30
No Use 0.00 10
Ciprofloxacin
/
Salmonella spp. (Typing Performed)
See: Table 2 AMR+ (%) AMR- (%) Total (n)
Pulsed CTC Use 0.00 30
No Use 0.00 10
Gentamicin
/
Salmonella spp. (Typing Performed)
See: Table 2 AMR+ (%) AMR- (%) Total (n)
Pulsed CTC Use 0.00 30
No Use 0.00 10
Nalidixic Acid
/
Salmonella spp. (Typing Performed)
See: Table 2 AMR+ (%) AMR- (%) Total (n)
Pulsed CTC Use 0.00 30
No Use 0.00 10
Sulfamethoxazole And Trimethoprim
/
Salmonella spp. (Typing Performed)
See: Table 2 AMR+ (%) AMR- (%) Total (n)
Pulsed CTC Use 0.00 30
No Use 0.00 10
Chloramphenicol
/
Salmonella spp. (Typing Performed)
See: Table 2 AMR+ (%) AMR- (%) Total (n)
Pulsed CTC Use 10.00 30
No Use 0.00 10
Kanamycin
/
Salmonella spp. (Typing Performed)
See: Table 2 AMR+ (%) AMR- (%) Total (n)
Pulsed CTC Use 0.00 30
No Use 10.00 10
Streptomycin
/
Salmonella spp. (Typing Performed)
See: Table 2 AMR+ (%) AMR- (%) Total (n)
Pulsed CTC Use 100.00 30
No Use 100.00 10
Sulfamethoxazole
/
Salmonella spp. (Typing Performed)
See: Table 2 AMR+ (%) AMR- (%) Total (n)
Pulsed CTC Use 100.00 30
No Use 90.00 10
Amikacin
/
Escherichia coli
See: Table 3 AMR+ (%) AMR- (%) Total (n)
Pulsed CTC Use 0.00 146
No Use 0.00 128
Ceftriaxone
/
Escherichia coli
See: Table 3 AMR+ (%) AMR- (%) Total (n)
Pulsed CTC Use 0.00 146
No Use 0.00 128
Ciprofloxacin
/
Escherichia coli
See: Table 3 AMR+ (%) AMR- (%) Total (n)
Pulsed CTC Use 0.00 146
No Use 0.00 128
Nalidixic Acid
/
Escherichia coli
See: Table 3 AMR+ (%) AMR- (%) Total (n)
Pulsed CTC Use 0.00 146
No Use 0.00 128
Chloramphenicol
/
Escherichia coli
See: Table 3 AMR+ (%) AMR- (%) Total (n)
Pulsed CTC Use 5.50 146
No Use 10.20 128
Gentamicin
/
Escherichia coli
See: Table 3 AMR+ (%) AMR- (%) Total (n)
Pulsed CTC Use 2.70 146
No Use 6.20 128
Kanamycin
/
Escherichia coli
See: Table 3 AMR+ (%) AMR- (%) Total (n)
Pulsed CTC Use 26.70 146
No Use 20.30 128
Streptomycin
/
Escherichia coli
See: Table 3 AMR+ (%) AMR- (%) Total (n)
Pulsed CTC Use 26.70 146
No Use 17.20 128
Sulfamethoxazole
/
Escherichia coli
See: Table 3 AMR+ (%) AMR- (%) Total (n)
Pulsed CTC Use 24.00 146
No Use 18.80 128
Sulfamethoxazole And Trimethoprim
/
Escherichia coli
See: Table 3 AMR+ (%) AMR- (%) Total (n)
Pulsed CTC Use 1.40 146
No Use 0.80 128